Search Results 7061-7070 of 25506 for oral

  1. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  2. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

    Able to take oral medication without crushing, dissolving or chewing tablets. Patients must have a life expectancy ≥ 6 months. Patients may have received ...

  3. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

    Received oral or IV antibiotics within 2 weeks prior to Cycle 1 Day 1. Significant cardiovascular disease, such as New York Heart Association (NYHA) cardiac ...

  4. Celebrating the gift of life: Cousins raise awareness for organ donation on National Donor Day - Mayo Clinic News Network

    This National Donor Day, an annual observance dedicated to spreading awareness and education about organ, eye and tissue donation, M.

  5. Publications - Alicia Algeciras-Schimnich, Ph.D. - Mayo Clinic

    2023 Mar; 29(3):193-198. Epub 2023 Jan 07. View PubMed; Ashcherkin N, Patel AA, Algeciras-Schimnich A, Doshi KB. Bone turnover markers to monitor oral ...

  6. Stereotactic Radiosurgery Clinical Trials - Mayo Clinic Research

    ... Oral Word Association (COWA) test, and the Trail Making Test (TMT). SPORT-DMG Rochester, MN; Scottsdale/Phoenix, AZ. The purpose of this study is to evaluate ...

  7. Fever treatment: Quick guide to treating a fever - Mayo Clinic

    The values listed in the table below are for temperatures taken with rectal and oral thermometers. These thermometers provide the most accurate measurement ...

  8. Publications - Folakemi T. Odedina, Ph.D. - Mayo Clinic

    Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients. Cancer ...

  9. A Study to Evaluate AZ-010 to Treat Moderate-to-Severe Cyclic Vomiting Syndrome - Mayo Clinic

    Oral contraceptive (combined, patch, vaginal ring, injectable, implant) in females;; Double-barrier method (any combination of physical and chemical methods); ...

  10. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy - Mayo Clinic

    ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...